Elevated SOCS3 mRNA expression in JAK2 V617F-positive MPN patients was confirmed by individual quantitative PCR (qPCR) assay of peripheral blood cDNA samples from the 26 patients and 11 healthy volunteers. Here, JAK2 is linked to myeloproliferative disorder.